Live Breaking News & Updates on Biodexa Pharmaceuticals Chart

Stay updated with breaking news from Biodexa pharmaceuticals chart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biodexa Enters Into Exclusive License to eRapa, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)

26.04.2024 - April 26, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Enters Into Exclusive License to eRapa, a Phase 3 Ready Asset for theTreatment of Familial Adenomatous Polyposis (FAP) Worldwide rights come with $17 million in . Seite 1 ....

Emtora Biosciences , Biodexa Pharmaceuticals , National Cancer Institute , Research Institute Of Texas , Rapamycin Holdings Inc , National Institutes Of Health , Pivotal Phase , Cancer Prevention , Research Institute , Non Muscle Invasive Bladder Cancer , National Institutes , Rapamycin Holdings , Biodexa Pharmaceuticals Chart , Iodexa Pharmaceuticals Kurs , Iodexa Pharmaceuticals Aktie ,

Biodexa to Present Recruitment and Treatment Update in Phase 1 Study of MTX-110 (MAGIC-G1 Study) in Patients with Recurrent Glioblastoma at 2023 Annual European Association of Neuro-Oncology Meeting (EANO)

21.09.2023 - Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa to Present Recruitment and Treatment Update in Phase 1 Study of MTX-110 (MAGIC-G1 Study) in Patients with Recurrent Glioblastoma at 2023 Annual European Association of Neuro-Oncology . Seite 1 ....

Dmitry Zamoryakhin , Biodexa Pharmaceuticals Chart , Iodexa Pharmaceuticals Kurs , Iodexa Pharmaceuticals Aktie ,